Identification of genetic alterations in Metastatic Castration Resistant Prostate Cancer (mCRPC) may provide scientists and clinicians with a list of new targets for drug research and development. Recently published in Cell, Robinson et al. present the first look at genetic data from mCRPC lesions gathered over multiple years and from many institutions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847990 | PMC |
http://dx.doi.org/10.1080/15384047.2016.1139270 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!